Adicet Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
(WorldNews Politics)

PDF Version MENLO PARK, Calif. and BOSTON, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (`Adicet`) (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that on September 17, 2020, the Compensation Committee of Adicet`s Board of Directors granted non-qualified stock options of 195,898 shares...